Answers are grounded in this paper and cite their sources.
Background: Pseudohypoparathyroidism type 1b (PHP1b) is a rare genetic disorder characterized by renal parathyroid hormone (PTH) resistance. While chronic secondary hyperparathyroidism is common, progression to autonomous tertiary hyperparathyroidism remains exceptionally rare, with only five cases reported in the literature. Case description: We report the case of a 66-year-old Caucasian woman with an autosomal dominant form of PHP1b (maternal transmission of a STX16 gene deletion) diagnosed at age 35. After 31 years of stable disease managed with calcitriol, she presented with persistent hypercalcemia for 5 years. Longitudinal follow-up revealed a dramatic, tenfold surge in serum intact PTH levels, peaking at 932 ng/l. Physical examination showed a mildly rounded facies and brain imaging revealed basal ganglia calcifications. A neck ultrasound and technetium-99m sestamibi scintigraphy confirmed a right medial parathyroid nodule. The patient underwent surgical resection of the lesion. Histopathology confirmed a follicular parathyroid adenoma. Postoperatively, serum calcium and PTH levels normalized rapidly and remained stable at 6-month follow-up. Conclusion: Tertiary hyperparathyroidism is a rare but critical long-term complication of PHP1b that typically occurs after decades of stimulation. In patients with PHP1b, the onset of hypercalcemia accompanied by a significant, progressive increase in PTH levels should immediately raise suspicion of an autonomous parathyroid adenoma and prompt targeted imaging and surgical management.
No takes yet. Share an insight, caveat, or question.
Xavier Vandemergel (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: